Feedback / Questions
briquilimab (JSP191) - Jasper Therap
https://www.manilatimes.net/2025/06/14/tmt-newswire/globenewswire/jasper-therapeutics-reports-positive-data-from-180mg-cohort-in-spotlight-study-of-briquilimab-in-chronic-inducible-urticaria/2133477
Jun 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next